The President began his Address by reviewing the history of chemotherapy from the nineteenth century, through the Ehrlich period and the pre-sulphonamide period, to the sulphonamide period, which led to Fildes' concept of competitive antagonism as a possible basis for drug action, and to attempts to design chemotherapeutic substances by the synthesis of compounds closely related to essential metabolites or growth factors. He then turned to the present day.
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The search for new and more effective chemicals demands a particularly close collaboration between scientists of many different disciplines. Discovery of a relationship between potentially useful biological activity and some particular molecular structure leads to two lines of investigation: (1) Screening of minor molecular variations produced by the chemist, and (2) studies of the distribution, mode of action and metabolism of the drug in the animal body. In spite of advances in biochemical knowledge, the search for new drugs is still largely a game of chance, sometimes rather contemptuously referred to as 'molecular roulette'. This must not be despised as a method, for it has already produced a large number of useful prizes. The knowledge which is being collected and recorded must in time increase our understanding of biochemical processes and enable us to direct the search for new chemicals into more predictable channels.
Great changes in biological activity sometimes follow slight alterations in chemical structure. For example, when two methyl groups are removwd from suramin, there is almost complete loss of trypanosomacidal activity (Goodwin & Rose 1958) The introduction of one additional double bond into the cortisone molecule greatly enhances anti-inflammatory activity without concomitant increase in water and salt retention (Tausk 1961) .
Choice of screening techniques is important as unsuitable tests may exclude potentially useful drugs. In vitro culture methods may be simple and relatively inexpensive, but take no account of metabolism of the drug in the host's body. It is fairly easy, for instance, to kill in the test tube Dermatophilus dermatonomus, the causal organism of mycotic dermatitis in sheep, but the same chemicals are relatively ineffective in the sheep's fleece. Many protozoa and parasitic worms cannot yet be maintained in culture, so that recourse must be had to animal tests even at the early screening stage. This is expensive and requires relatively large quantities of chemicals for testing.
In the insecticidal field the problem is simpler. Minute measured drops of the test substance can be applied to the thorax of a captive fly, and this requires only minute quantities of the candidate chemicals. Large numbers of compounds can be tested in this way, even when the supply of each is limited; the minute quantities needed eliminatedanger to the operator from unknown mammalian toxicity.
Mr Harbour went on to describe some of the work with which he and his colleagues were concerned.
Blowfly myiasis is an economically important disorder of sheep, and there is a constant search for new insecticides for its control. The screening test used is a modification of that devised bydu Toit & Fiedler (1953) . Larvwe are allowed to grow in bovine or horse serum with cotton-wool, and the chemical under test is introduced in a series of dilutions in the serum.
The testing of anthelmintics poses more complex problems; there is no really satisfactory invitro test and infestations of small animals are of limited use. For an anthelmintic for ruminants it is usually necessary to test in sheep at an early stage. Single sheep with a mixed infestation may be used at first, dead worms passed in the faces being identified, and, after slaughter of the sheep, counts of survivors in the stomach and intestinal contents can be made. Mammalian toxicity of the compounds must also be assessed.
The results of the preliminary biological tests will show which compounds are suitable for further development. The veterinarian has an advantage here as, unlike his medical colleague, he can usually pass directly to the animal for which the remedy is required. Larger quantities of the drug will be needed, and the chemist must consider methods of production. The pharmacist must decide on the best mode of presentation, and the formulations are again tested by the biologist to ensure that the process has not affected activity or increased toxicity. Any preparation produced should have a satisfactory shelf life, even under adverse storage conditions, or, if instability is unavoidable, the storage conditions must be carefully defined. Further tests are necessary to determine that the drug is not retained in flesh or milk to a dangerous extent. In all this work, the advice of the statistician is essential.
A new compound for veterinary use must be tested in the field on different species of animals under widely varying conditions, preferably in several different countries. These tests should involve hundreds, or even thousands, of animals.
For use in the tropics, effective insecticides against ectoparasites have to be stable during long journeys, must be easy for the farmer to mix in his dipping tank, and must remain active in the presence of large amounts of organic matter at an alkaline pH for months at a time. This is in striking contrast to the sterile, packed medical product intended for injection.
The introduction of an active synergist may make it possible to use a very expensive compound at much lower concentrations than would otherwise be necessary. Aerosol fly sprays contain an extract of pyrethrum together with a synergist, such as piperonyl butoxide. Sulphonamides and pyrimethamine are synergistic in action on the malarial parasite, and block different parts of the same metabolic pathway. These drugs have not been used for the treatment of malaria, but a similar combination has been shown to be effective in coccidiosis in chickens. Kingsbury (1961) demonstrated that combinations of certain organophosphorus esters and phenothiazine act synergistically as anthelmintics in sheep, and Downing (1961) showed that piperonyl butoxide and rotenone were synergistic against the itch mite (Psorergates ovis).
The drug manufacturers' successes have to be paid for. The average drug may have cost about £200,000 before reaching the clinical trial stage; British manufacturers spend about £7,000,000 a year on drug research. The successes have to pay for the failures, and it is small wonder that some Continental manufacturers, concentrating on the successes ofothers, can produce drugs at lowercost than the originators.
Many compounds may be in existence which are valued for one particular biological activity, but which, if suitably tested, would be found useful in quite unrelated fields. Hexachlorophane, for example, which has been used for many years as a skin disinfectant, a deodorant in soaps and as a constituent of toothpastes, has recently been found to be a useful drug for the control of the liver fluke, Fasciola hepatica (Dorsman 1959) . It is to be hoped that closer co-operation between firms concerned with different aspects of drug development will in future lead to increased 'cross-fertilization' in industry, and to improved assessment of the potentialities of new compounds.
Mr Harbour then went on to review progress in the insecticide and anthelmintic fields.
Since the discovery of DDT many new insecticides have been evolved. Most have been used first in crop protection; some have a profound effect on animal parasites. The new compounds fall into two classes, chlorinated hydrocarbons and organophosphorus compounds, the latter being developed originally from wartime research on nerve gases. Development of benzene hexachloride led to the disappearance of sheep scab in this and some other countries, and reduced it to insignificant proportions in others. Sheep scab has been an important cause of loss of sheep since Biblical times. Dieldrin, another chlorinated hydrocarbon, has made possible excellent control of the sheep blowfly. Some of the new organophosphorus compounds are effective against the hide-damaging warble flies of the hypoderma genus, and the South American cattle pest, dermatobia.
In the anthelmintic field, several new drugs are available for the control of intestinal nematodes of sheep, cattle and horses. There has been 'crossfertilization' here, for some of the compounds first found effective as insecticides have later proved useful as anthelmintics. There is a long list of compounds which have been developed for use in the veterinary field, and which will supplement or replace phenothiazine, for many years the principal anthelmintic. Some, notably diethylcarbamazine and the piperazines, have valuable medical applications. Close co-operation between the medical and veterinary helminthologist is to the advantage of both.
Many problems beset those who develop new compounds, and among these are the development of drug resistance, toxicity, and shifts in the natural population leading to new diseases.
Resistance to insecticides has been troublesome in crop protection and public health. Resistance in the one-host cattle tick (species and subspecies of boophilus) has caused concern in South Africa, Australia and South America. Many different compounds have therefore been developed for the control of this pest. In some areas of Australia and South Africa, the fly Lucilia cuprina has developed resistance to dieldrin. In the anthelmintic field, there is little evidence of any serious development of resistance. At present, the only remedy for resistance is the discovery of new effective compounds, but studies of the mechanisms of resistance may lead to other methods of attack.
Toxicity may not become apparent until a drug has been used on a very large scale. Carbon tetrachloride as a liver fluke remedy, for example, at first appeared effective and absolutely safe, but later troublesome instances of flock-susceptibility occurred. The reason for this occasional severe toxicity is unknown, but in some flocks losses may be heavy when this compound is used.
Sometimes, the control of one parasite will create conditions which favour another. There are many entomological examples of this. In the veterinary field, there is a new, disease syndrome (nematodiriasis) in lambs, a result of development of pathogenicity in a parasite once thought to be harmless. The cause of this is not clear, but it may have been produced by the widespread use of phenothiazine which has removed populations of competing nematodes.
Nature is versatile, and biological variations will see to it that new problems arise. We can, however, look back on a number of useful milestones along the road, milestones marking some major advances in disease control. Increasing biochemical knowledge will in time enable us to take short cuts and reach our objectives more easily and quickly. Meanwhile, the gambling instinct in all of us is strong and the feeling of excitement and exhilaration which comes with the finding of a new lead, will always be a reward for the drudgery of many thousands of chemists patiently making their hundreds of thousands of chemical compounds for the ultimate betterment of conditions of living for man and all his animals.
Meeting December 20 1961 The Provision and Use of Pathogen-free Laboratory Animals Dr W Lane-Petter (Carshalton, Surrey)
Provision of Pathogen-free Animals
All who work with laboratory animals have been frustrated from time to time by the presence within their colonies of disease, which either leads to intercurrent death of some of the animals under experiment, or perhaps to a vitiation of their experimental results arising out of unwanted or even unsuspected infection. It is impossible to measure the extent of this frustration, but in too many instances it is large, and sometimes overwhelming.
This has led, for many years, to a demand for 'better' animals; animals that are 'disease free', 'healthy', or otherwise free of the customary drawbacks. But in fact, all conventional laboratory animals may, and usually do, harbour a collection of pathogens, including ectoparasites, endoparasites, protozoa, bacteria, and viruses, which results in overt or potential disease. In many cases, the presence of any of these pathogens may be thought to be of little moment: this may be something of a fool's paradise. Only those who have used pathogen-free animals can assess the full disadvantages of their conventional counterparts.
It is necessary to draw a distinction between infection and disease. Clinicians, whether medical or veterinary, are normally dealing with disease; that is, with the manifestations of morbid processes due, in the present context, to the presence and activity of pathogenic organisms. The situation is one in which the pathogen has created a recognizable departure from health in the host. It is the clinician's function to deal a swingeing blow to the pathogen and, with the help of vis' medicatrix naturce, to restore the integrity of the host.
With laboratory animals the situation is different. When infection betrays its presence by causing disease, the affected animals are removed and killedfirst, because they are a focus of infection of their neighbours, and second, because for most purposes they are no longer useful for experiments. But the stringency does not stop here. The presence of infection, even
